ASC/TERT3002022-11-23T12:26:44+00:00

Adipose tissue

ASC/TERT300

Evercyte ́s ASC/TERT300 cell line has been developed from adipose-derived mesenchymal stromal cells, can be grown without limitations, shows typical markers and functions of MSCs and therefore represents a valuable model for studying processes such as differentiation, inflammation, tissue homeostasis and repair. In recent years evidence has accumulated that the potency of mesenchymal stromal cells at least in part is mediated by secreted extracellular vesicles (EVs). ASC/TERT300 cell line has been established under conditions that will allow production of EVs for clinical applications.

Print Friendly, PDF & Email

from

€ 1300,–

ASC/TERT300
Cat#: CHT-001-0300

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Tissue targeting: recombinant EVs

engineering of CD81 on extracellular vesicles to target specific cell surface proteins

ASC/TERT300-B

adipose-derived mesenchymal stem cells grown in human platelet lysate (hPL) containing medium are available as well

Related Services

contact us if you are interested in engineering of extracellular vesicles to target specific cell surface proteins

MSCs for production of clinical grade extracellular vesicles

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

all about our
EV cell factories

Related Products

mesenchymal stromal cells for production of clinical grade extracellular vesicles

Related Services

production and characterization of extracellualr vesicles

 

Generation of recombinant EVs for tissue targeting!

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Print Friendly, PDF & Email

from

€ 1300,–

ASC/TERT300
Cat#: CHT-001-0300

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Title

Go to Top